First Header Logo Second Header Logo

Omar Sangueza

Concepts (521)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Skin Neoplasms
51
2019
207
7.910
Why?
Skin
25
2018
205
3.690
Why?
Exanthema
4
2018
21
1.920
Why?
Immunohistochemistry
27
2019
520
1.680
Why?
Carcinoma, Squamous Cell
8
2019
149
1.490
Why?
Skin Diseases
11
2017
138
1.470
Why?
Humans
130
2019
29553
1.410
Why?
Skin Diseases, Vascular
6
2019
9
1.400
Why?
Dermatology
11
2017
154
1.240
Why?
Xanthomatosis
2
2017
3
1.210
Why?
Diagnosis, Differential
29
2019
493
1.180
Why?
Hemangioendothelioma
6
2015
11
1.100
Why?
Pathology
7
2013
20
1.060
Why?
Middle Aged
58
2019
10936
1.010
Why?
Female
73
2019
18379
1.000
Why?
Mycosis Fungoides
6
2017
13
0.990
Why?
Soft Tissue Neoplasms
5
2018
35
0.970
Why?
Tattooing
3
2017
7
0.940
Why?
Melanoma
10
2014
148
0.930
Why?
Pellagra
2
2016
3
0.930
Why?
Lichen Sclerosus et Atrophicus
2
2017
7
0.900
Why?
Erythema
5
2016
27
0.880
Why?
Adult
43
2018
8528
0.860
Why?
Biopsy, Needle
9
2019
90
0.860
Why?
Male
58
2019
18012
0.840
Why?
Aged
41
2019
9590
0.800
Why?
Telangiectasis
3
2019
3
0.790
Why?
Carcinoma, Merkel Cell
2
2019
10
0.770
Why?
Sweet Syndrome
2
2019
7
0.740
Why?
Immunocompromised Host
3
2019
43
0.740
Why?
Biopsy
12
2017
243
0.740
Why?
Collagen Type I
1
2019
39
0.700
Why?
Cellulitis
1
2019
11
0.700
Why?
Streptococcal Infections
1
2019
20
0.690
Why?
Deficiency Diseases
2
2010
4
0.680
Why?
Neoplasms, Multiple Primary
1
2019
20
0.680
Why?
Zinc
2
2010
32
0.660
Why?
Leukemic Infiltration
1
2018
2
0.660
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
2018
9
0.650
Why?
Ossification, Heterotopic
2
2009
14
0.650
Why?
Anti-Bacterial Agents
2
2019
286
0.640
Why?
Pagetoid Reticulosis
1
2018
2
0.630
Why?
Coloring Agents
2
2017
30
0.610
Why?
Fibroma
3
2014
11
0.610
Why?
Certification
3
2009
25
0.610
Why?
Mast Cells
2
2017
17
0.610
Why?
Panniculitis, Lupus Erythematosus
3
2014
5
0.610
Why?
Urticaria Pigmentosa
1
2017
1
0.600
Why?
Pathology, Clinical
3
2018
14
0.580
Why?
Hand Dermatoses
2
2016
10
0.580
Why?
Hemangiosarcoma
4
2010
8
0.540
Why?
Thigh
2
2019
39
0.540
Why?
Pregnancy Complications, Neoplastic
1
2015
4
0.530
Why?
Scalp
2
2007
33
0.510
Why?
Dermatitis
4
2017
20
0.490
Why?
Blood Vessels
2
2009
47
0.480
Why?
Histiocytoma, Benign Fibrous
4
2009
4
0.480
Why?
Neoplasm Invasiveness
5
2014
189
0.470
Why?
Neoplasms, Adnexal and Skin Appendage
1
2013
2
0.460
Why?
Neoplastic Syndromes, Hereditary
1
2013
3
0.460
Why?
Head and Neck Neoplasms
2
2007
123
0.460
Why?
Neoplasm Recurrence, Local
1
2015
337
0.430
Why?
Parakeratosis
2
2003
2
0.430
Why?
Axilla
2
2003
15
0.420
Why?
Hemangioma
3
2009
18
0.420
Why?
Treatment Outcome
8
2019
3128
0.420
Why?
Fingers
2
2008
57
0.420
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2002
41
0.410
Why?
Keratinocytes
2
2010
26
0.400
Why?
Polycythemia Vera
1
2010
2
0.380
Why?
Paracoccidioidomycosis
2
2009
2
0.380
Why?
Niacin
1
2010
7
0.380
Why?
Acantholysis
1
2010
1
0.380
Why?
Ichthyosis
1
2010
1
0.380
Why?
Epidermis
5
2011
25
0.370
Why?
Giant Cells
2
2009
4
0.360
Why?
Tongue Neoplasms
3
2003
5
0.360
Why?
Epithelioid Cells
1
2009
1
0.350
Why?
Perivascular Epithelioid Cell Neoplasms
1
2009
1
0.350
Why?
Desmin
1
2009
12
0.350
Why?
Mycoses
2
2009
13
0.350
Why?
Child
8
2017
2233
0.340
Why?
Sialoglycoproteins
2
2008
7
0.340
Why?
Osteoclasts
1
2009
22
0.340
Why?
Paracoccidioides
1
2009
1
0.340
Why?
Bottle-Nosed Dolphin
1
2009
1
0.340
Why?
Dermatomyositis
1
2009
19
0.330
Why?
Neoplasms, Vascular Tissue
3
2013
7
0.320
Why?
Lymphoma, B-Cell
2
2002
12
0.320
Why?
Endothelium, Lymphatic
1
2008
1
0.320
Why?
Vascular Endothelial Growth Factor Receptor-3
1
2008
1
0.320
Why?
Keratoacanthoma
1
2008
1
0.310
Why?
Antigens, CD
4
2009
100
0.310
Why?
Mouth Mucosa
1
2008
29
0.310
Why?
Transglutaminases
1
2007
1
0.310
Why?
Epidermal Cyst
1
2007
4
0.310
Why?
Acrodermatitis
1
2007
1
0.300
Why?
Arm
2
2017
31
0.300
Why?
Renal Insufficiency
1
2007
53
0.300
Why?
Carcinoma
3
2013
89
0.290
Why?
Aged, 80 and over
14
2014
3764
0.290
Why?
Upper Extremity
3
2017
53
0.280
Why?
Hypopigmentation
3
2017
7
0.270
Why?
Hamartoma
2
1997
11
0.270
Why?
Neurilemmoma
2
2005
14
0.270
Why?
Opportunistic Infections
2
2002
9
0.270
Why?
Adolescent
12
2013
3284
0.270
Why?
Lower Extremity
2
2017
97
0.270
Why?
Granuloma
2
2002
13
0.270
Why?
Specialty Boards
1
2005
9
0.260
Why?
Eyelid Neoplasms
2
2018
3
0.260
Why?
Risk Assessment
4
2019
1329
0.260
Why?
Carcinoma, Basal Cell
3
2014
27
0.250
Why?
Drug Therapy, Combination
3
2019
275
0.250
Why?
Mass Screening
1
2007
227
0.250
Why?
Education, Medical, Graduate
3
2012
116
0.250
Why?
Dermatomycoses
2
2002
6
0.250
Why?
Eye Neoplasms
1
2004
4
0.240
Why?
Retroperitoneal Neoplasms
1
2004
11
0.240
Why?
Facial Neoplasms
2
2001
10
0.240
Why?
Lupus Erythematosus, Discoid
2
2004
8
0.230
Why?
Remission, Spontaneous
4
2015
14
0.230
Why?
Glomus Tumor
3
2017
6
0.230
Why?
Ganglioneuroma
1
2003
2
0.230
Why?
Sarcoma, Alveolar Soft Part
1
2003
1
0.230
Why?
Flow Cytometry
3
2005
173
0.220
Why?
Multiple Myeloma
1
2003
15
0.220
Why?
Prognosis
6
2015
1372
0.220
Why?
Fusarium
1
2002
1
0.220
Why?
Fibrosarcoma
1
2002
3
0.220
Why?
Keratosis, Actinic
2
2015
18
0.220
Why?
Lymph Nodes
2
2019
94
0.220
Why?
Eosinophils
2
2014
48
0.210
Why?
Rare Diseases
2
2019
20
0.210
Why?
Tetrahydronaphthalenes
1
2002
7
0.210
Why?
Gingival Neoplasms
1
2002
1
0.210
Why?
DNA, Neoplasm
2
1993
58
0.210
Why?
Arthritis, Rheumatoid
1
2002
33
0.210
Why?
Periodontitis
1
2002
9
0.210
Why?
Lymphoma, Large B-Cell, Diffuse
1
2002
15
0.210
Why?
Neoplasm Proteins
6
2009
141
0.210
Why?
Precancerous Conditions
2
2013
24
0.200
Why?
Carcinoma, Skin Appendage
1
2001
1
0.200
Why?
Darier Disease
1
2001
2
0.200
Why?
S100 Proteins
5
2005
18
0.200
Why?
Antigens, Neoplasm
4
2009
44
0.190
Why?
Toes
2
2017
16
0.190
Why?
Hyperpigmentation
2
2013
17
0.190
Why?
Endothelium, Vascular
4
2009
145
0.190
Why?
Image Processing, Computer-Assisted
2
1993
242
0.190
Why?
Immunosuppressive Agents
2
2006
168
0.190
Why?
Neoplasms, Basal Cell
1
2000
2
0.180
Why?
Proliferating Cell Nuclear Antigen
1
2000
13
0.180
Why?
Proto-Oncogene Proteins c-bcl-2
1
2000
37
0.180
Why?
Dermis
5
2009
12
0.180
Why?
Lymphatic Metastasis
2
2019
156
0.180
Why?
Predictive Value of Tests
5
2013
796
0.180
Why?
Ki-67 Antigen
1
2000
29
0.180
Why?
Tumor Suppressor Protein p53
1
2000
78
0.180
Why?
Streptococcus
1
2019
7
0.180
Why?
Pemphigoid, Bullous
1
2019
6
0.180
Why?
Knee
1
2019
31
0.170
Why?
Elbow
1
2019
25
0.170
Why?
Retrospective Studies
7
2011
3144
0.170
Why?
Xanthogranuloma, Juvenile
1
1999
2
0.170
Why?
Fever
1
2019
56
0.170
Why?
Eccrine Glands
2
1997
2
0.170
Why?
Arteriovenous Fistula
1
1999
14
0.170
Why?
Lymphoma, Non-Hodgkin
1
1999
20
0.170
Why?
Actinomycosis
1
1998
2
0.160
Why?
Oral Ulcer
1
1998
5
0.160
Why?
Antigens, CD7
1
2018
4
0.160
Why?
Chondroma
1
2018
2
0.160
Why?
Palate
1
1998
5
0.160
Why?
Bone Marrow Examination
1
2018
8
0.160
Why?
Nevus
2
2004
15
0.160
Why?
Vascular Neoplasms
3
2009
14
0.160
Why?
Vulvar Neoplasms
2
2013
6
0.160
Why?
Child, Preschool
6
2013
1172
0.160
Why?
Foot
1
2018
40
0.150
Why?
Prednisone
3
2008
43
0.150
Why?
Severity of Illness Index
2
2019
864
0.150
Why?
Image Interpretation, Computer-Assisted
1
2018
113
0.150
Why?
Dermatitis, Allergic Contact
1
2017
11
0.150
Why?
Lacrimal Apparatus Diseases
1
2017
2
0.150
Why?
Eyelids
1
2017
9
0.150
Why?
Nail Diseases
1
2017
3
0.150
Why?
Conjunctiva
1
2017
5
0.150
Why?
Lacrimal Apparatus
1
2017
6
0.150
Why?
Angiomyoma
1
2017
3
0.150
Why?
Conjunctival Diseases
1
2017
4
0.150
Why?
Administration, Oral
2
2008
172
0.150
Why?
Hyperplasia
5
2013
38
0.140
Why?
Skin Pigmentation
1
2017
23
0.140
Why?
Cladribine
1
1996
1
0.140
Why?
Myxedema
1
1996
3
0.140
Why?
Cell Differentiation
3
2013
438
0.140
Why?
Scleroderma, Systemic
1
1996
7
0.140
Why?
Immunoenzyme Techniques
5
2004
47
0.140
Why?
Telemedicine
1
2017
79
0.140
Why?
Terminology as Topic
2
1993
63
0.140
Why?
Sparganosis
1
2016
1
0.140
Why?
Sparganum
1
2016
1
0.140
Why?
Zoonoses
1
2016
3
0.140
Why?
Skin Diseases, Infectious
1
2016
3
0.140
Why?
Antinematodal Agents
1
2015
1
0.140
Why?
Skin Diseases, Parasitic
1
2015
1
0.140
Why?
Nematoda
1
2015
2
0.140
Why?
Nematode Infections
1
2015
2
0.140
Why?
Emergency Service, Hospital
1
2019
440
0.130
Why?
Sarcoma, Kaposi
3
2002
7
0.130
Why?
Lymphocytes
3
2010
55
0.130
Why?
Hidradenitis
1
1995
1
0.130
Why?
Liver Diseases, Alcoholic
1
1995
5
0.130
Why?
AIDS-Related Opportunistic Infections
1
1995
10
0.130
Why?
Herpes Simplex
1
1995
12
0.130
Why?
Herpes Zoster
1
1995
9
0.130
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2018
401
0.130
Why?
Administration, Topical
2
2007
130
0.130
Why?
Kidney Transplantation
1
2019
353
0.130
Why?
Hemochromatosis
1
1995
70
0.120
Why?
Infant
5
2013
976
0.120
Why?
Liver Diseases
1
1995
62
0.120
Why?
Breast Neoplasms
2
2002
680
0.120
Why?
Rhinophyma
1
1994
2
0.120
Why?
Mohs Surgery
2
2007
16
0.120
Why?
Europe
3
2016
78
0.120
Why?
Education, Medical, Continuing
2
2012
45
0.120
Why?
Chordoma
1
1994
7
0.120
Why?
Pruritus
1
2014
58
0.120
Why?
African Americans
1
2001
1375
0.120
Why?
Infrared Rays
1
2013
18
0.110
Why?
Leishmaniasis, Mucocutaneous
1
1993
1
0.110
Why?
Wrestling
1
1993
2
0.110
Why?
Combined Modality Therapy
3
2015
525
0.110
Why?
Neoplasms, Radiation-Induced
1
2013
13
0.110
Why?
Tinea
1
1993
4
0.110
Why?
Penile Neoplasms
2
2004
6
0.110
Why?
Dysplastic Nevus Syndrome
1
1993
3
0.110
Why?
Calcinosis
1
2014
143
0.110
Why?
Lymphoma
2
1993
36
0.110
Why?
Contrast Media
2
2007
124
0.110
Why?
Disease Outbreaks
1
1993
35
0.110
Why?
Neoplasms, Second Primary
1
1992
16
0.110
Why?
PUVA Therapy
2
2009
22
0.110
Why?
Back
2
2010
3
0.110
Why?
Myoepithelioma
2
2003
2
0.110
Why?
Glucocorticoids
3
2009
149
0.110
Why?
Pregnancy
1
2015
825
0.110
Why?
Neoplasm Staging
3
2010
441
0.100
Why?
Pain
1
2014
285
0.100
Why?
T-Lymphocytes
1
1992
116
0.100
Why?
Phenotype
1
2013
633
0.100
Why?
Eczema
1
2011
12
0.100
Why?
Histiocytes
2
2009
3
0.100
Why?
Nerve Fibers
1
2011
31
0.100
Why?
Inflammation
1
2014
511
0.100
Why?
Groin
1
2010
5
0.100
Why?
Rhabdomyoma
1
1990
3
0.090
Why?
Lymphangioma
2
2002
6
0.090
Why?
Evidence-Based Medicine
2
2015
209
0.090
Why?
Leg
1
2010
57
0.090
Why?
DNA
1
1992
209
0.090
Why?
Hutchinson's Melanotic Freckle
1
2010
2
0.090
Why?
Governing Board
1
2009
1
0.090
Why?
Paget's Disease, Mammary
2
2002
3
0.090
Why?
Fibrosis
2
2007
104
0.090
Why?
Genetic Predisposition to Disease
1
2013
840
0.090
Why?
History, 21st Century
1
2009
49
0.090
Why?
History, 20th Century
1
2009
69
0.090
Why?
Radiography
2
2008
355
0.090
Why?
Technetium Tc 99m Sulfur Colloid
1
2009
6
0.090
Why?
Actins
1
2009
52
0.090
Why?
Histiocytosis
1
2009
1
0.090
Why?
Lymphatic Vessels
1
2009
5
0.090
Why?
Clobetasol
1
2009
25
0.090
Why?
Brazil
1
2009
13
0.080
Why?
Purpura
2
1999
3
0.080
Why?
Mastocytosis, Cutaneous
1
2008
3
0.080
Why?
Radiopharmaceuticals
1
2009
89
0.080
Why?
Renal Dialysis
2
2003
265
0.080
Why?
Immunophenotyping
3
1993
50
0.080
Why?
Leukemia, Myelomonocytic, Chronic
1
2008
1
0.080
Why?
Granuloma Annulare
1
2008
2
0.080
Why?
Survival Analysis
2
2007
440
0.080
Why?
Lymphangiectasis
2
1999
3
0.080
Why?
Lip
1
2008
8
0.080
Why?
Melanocytes
3
2001
8
0.080
Why?
Neurothekeoma
1
2008
2
0.080
Why?
Histiocytosis, Langerhans-Cell
1
2008
5
0.080
Why?
Endothelial Cells
1
2009
180
0.080
Why?
Elastic Tissue
1
2007
2
0.080
Why?
Bone Diseases
1
2008
16
0.080
Why?
Lupus Erythematosus, Systemic
1
2009
145
0.080
Why?
Factor XIIIa
1
2007
1
0.080
Why?
Gadolinium
1
2007
19
0.080
Why?
Atrophy
1
2007
52
0.080
Why?
Methotrexate
1
2008
60
0.080
Why?
Antigens, Differentiation, Myelomonocytic
1
2007
22
0.080
Why?
Syndrome
1
2007
66
0.080
Why?
Injections, Intravenous
1
2007
73
0.070
Why?
Extremities
1
2007
48
0.070
Why?
Fibroblasts
1
2007
105
0.070
Why?
Career Choice
1
2007
40
0.070
Why?
Early Diagnosis
1
2007
62
0.070
Why?
Fellowships and Scholarships
1
2007
50
0.070
Why?
Radiotherapy, Adjuvant
1
2007
69
0.070
Why?
Family Practice
1
2007
49
0.070
Why?
Chemotherapy, Adjuvant
1
2007
163
0.070
Why?
Skin Ulcer
1
2006
10
0.070
Why?
Germany
1
2006
8
0.070
Why?
Keratins
3
1998
38
0.070
Why?
Antibodies, Monoclonal
1
2008
198
0.070
Why?
Academic Medical Centers
1
2007
150
0.070
Why?
Polychondritis, Relapsing
1
2006
2
0.070
Why?
Cytomegalovirus Infections
1
2006
25
0.070
Why?
Magnetic Resonance Imaging
3
2017
1225
0.070
Why?
Mycophenolic Acid
1
2006
28
0.070
Why?
Dilatation, Pathologic
2
2013
19
0.070
Why?
Animals
3
2016
7339
0.070
Why?
Microtubule-Associated Proteins
1
2005
33
0.060
Why?
Nevus, Blue
2
2002
2
0.060
Why?
Case-Control Studies
1
2007
861
0.060
Why?
Neuroblastoma
1
2005
32
0.060
Why?
Anti-Inflammatory Agents
1
2006
91
0.060
Why?
Necrosis
2
1995
53
0.060
Why?
Follow-Up Studies
2
2008
2124
0.060
Why?
Fatal Outcome
2
2008
79
0.060
Why?
Recombinant Fusion Proteins
1
2004
97
0.060
Why?
Randomized Controlled Trials as Topic
1
2007
471
0.060
Why?
Vasculitis, Leukocytoclastic, Cutaneous
1
2004
2
0.060
Why?
Immunoglobulin G
1
2004
105
0.060
Why?
Neurofilament Proteins
1
2003
11
0.060
Why?
Mixed Tumor, Malignant
1
2003
1
0.060
Why?
Glial Fibrillary Acidic Protein
1
2003
37
0.060
Why?
Genes, Retinoblastoma
1
2003
4
0.060
Why?
Triamcinolone
1
2003
11
0.060
Why?
Immunoglobulins
1
2003
12
0.060
Why?
Plasma Cells
1
2003
8
0.060
Why?
In Situ Hybridization, Fluorescence
1
2003
38
0.060
Why?
Cell Nucleus
2
1995
109
0.060
Why?
Gene Deletion
1
2003
65
0.060
Why?
Actinomycetales
1
2002
1
0.060
Why?
Lip Neoplasms
1
2002
1
0.060
Why?
Syphilis, Cutaneous
1
2002
1
0.060
Why?
Skin Diseases, Papulosquamous
1
2002
1
0.060
Why?
Leukemia, Lymphoid
1
2002
2
0.060
Why?
Corynebacterium Infections
1
2002
2
0.060
Why?
Nevus, Epithelioid and Spindle Cell
1
2002
3
0.050
Why?
Angiomatosis
1
2002
3
0.050
Why?
Nevus, Pigmented
1
2002
5
0.050
Why?
Salivary Gland Neoplasms
1
2002
12
0.050
Why?
Cell Proliferation
1
2005
576
0.050
Why?
Adenoma
1
2002
35
0.050
Why?
Pigmentation Disorders
1
2002
8
0.050
Why?
Sarcoidosis
2
2002
27
0.050
Why?
Neutrophils
1
2002
102
0.050
Why?
Internship and Residency
1
2005
283
0.050
Why?
Dermatitis, Atopic
1
2002
86
0.050
Why?
Disease Progression
2
2015
574
0.050
Why?
Basal Cell Nevus Syndrome
1
1999
1
0.040
Why?
Psoriasis
1
2004
334
0.040
Why?
Leukemia, Hairy Cell
1
1999
1
0.040
Why?
Lymphoma, Large-Cell, Anaplastic
1
1999
1
0.040
Why?
Panniculitis
1
1999
3
0.040
Why?
Collagen Diseases
1
1999
5
0.040
Why?
Skin Diseases, Viral
1
1999
4
0.040
Why?
Skin Diseases, Genetic
1
1999
3
0.040
Why?
Graft vs Host Disease
1
1999
18
0.040
Why?
Vasculitis
1
1999
23
0.040
Why?
Bone Marrow Transplantation
1
1999
65
0.040
Why?
Diatrizoate Meglumine
1
1998
1
0.040
Why?
Hyperkeratosis, Epidermolytic
1
1998
1
0.040
Why?
Drug Eruptions
1
1998
8
0.040
Why?
Registries
2
2010
280
0.040
Why?
Angiolipoma
1
1998
1
0.040
Why?
Carcinoma, Adenosquamous
1
1998
3
0.040
Why?
Angiofibroma
1
1998
2
0.040
Why?
Hemangioendothelioma, Epithelioid
1
1998
3
0.040
Why?
Angiomyolipoma
1
1998
6
0.040
Why?
Myxoma
1
1998
4
0.040
Why?
Tomography, X-Ray Computed
1
2003
874
0.040
Why?
Software
1
2018
110
0.040
Why?
Angiomatosis, Bacillary
1
1997
1
0.040
Why?
Hemangioma, Cavernous
1
1997
3
0.040
Why?
Angiolymphoid Hyperplasia with Eosinophilia
1
1997
3
0.040
Why?
Granuloma, Pyogenic
1
1997
4
0.040
Why?
Hemangioma, Capillary
1
1997
3
0.040
Why?
Hemangiopericytoma
1
1997
6
0.040
Why?
Angiokeratoma
1
1997
2
0.040
Why?
Venules
1
1997
5
0.040
Why?
Lymphatic System
1
1997
2
0.040
Why?
Neoplasm Regression, Spontaneous
1
1997
6
0.040
Why?
Veins
1
1997
29
0.040
Why?
Capillaries
1
1997
23
0.040
Why?
Acute Disease
1
1998
239
0.040
Why?
Cell Lineage
1
1997
67
0.040
Why?
Aneurysm
1
1997
21
0.040
Why?
Oculomotor Muscles
1
1997
5
0.040
Why?
Eye Diseases
1
1997
5
0.040
Why?
Observer Variation
1
2017
96
0.040
Why?
Melanins
1
1996
6
0.040
Why?
Feasibility Studies
1
2017
270
0.040
Why?
Sentinel Lymph Node Biopsy
2
2009
69
0.040
Why?
Infusions, Intravenous
1
1996
85
0.030
Why?
Carcinoma, Ductal, Breast
1
1996
28
0.030
Why?
Seawater
1
2016
2
0.030
Why?
Praziquantel
1
2016
2
0.030
Why?
Blotting, Southern
2
1993
22
0.030
Why?
Genes, Immunoglobulin
2
1993
5
0.030
Why?
Gene Rearrangement
2
1993
10
0.030
Why?
Italy
1
2016
15
0.030
Why?
Anthelmintics
1
2016
3
0.030
Why?
Helminthiasis
1
2015
1
0.030
Why?
Helminths
1
2015
1
0.030
Why?
Tropical Climate
1
2015
1
0.030
Why?
Endemic Diseases
1
2015
4
0.030
Why?
Ophthalmologic Surgical Procedures
2
2010
3
0.030
Why?
Glucagonoma
1
1995
1
0.030
Why?
Sebaceous Glands
1
1995
2
0.030
Why?
Inclusion Bodies, Viral
1
1995
4
0.030
Why?
Young Adult
2
2013
2431
0.030
Why?
Tongue Diseases
1
1995
4
0.030
Why?
Hair Follicle
1
1995
9
0.030
Why?
Chromatin
1
1995
20
0.030
Why?
Edema
1
1995
30
0.030
Why?
Keratosis
1
1995
19
0.030
Why?
Cytoplasm
1
1995
32
0.030
Why?
Serum Albumin
1
1995
53
0.030
Why?
Kidney Failure, Chronic
1
1999
522
0.030
Why?
Facial Dermatoses
1
1994
19
0.030
Why?
Dental Instruments
1
1993
1
0.030
Why?
Nails
1
1993
6
0.030
Why?
Curettage
1
1993
9
0.030
Why?
Onychomycosis
1
1993
9
0.030
Why?
Leishmaniasis, Diffuse Cutaneous
1
1993
1
0.030
Why?
Bolivia
1
1993
2
0.030
Why?
Leishmaniasis, Cutaneous
1
1993
2
0.030
Why?
Specimen Handling
1
1993
31
0.030
Why?
Diploidy
1
1993
2
0.030
Why?
Vascular Malformations
1
2013
8
0.030
Why?
Pain Measurement
1
2014
365
0.030
Why?
Microscopy
1
1993
27
0.030
Why?
Antifungal Agents
1
1993
34
0.030
Why?
Stromal Cells
1
2013
70
0.030
Why?
Rhabdomyosarcoma
1
1992
6
0.030
Why?
Microscopy, Electron
1
1992
29
0.030
Why?
Credentialing
1
2012
8
0.030
Why?
Wilms Tumor
1
1992
14
0.030
Why?
Incidence
1
2015
1127
0.030
Why?
Task Performance and Analysis
1
2012
51
0.030
Why?
Ploidies
1
1992
7
0.030
Why?
Aneuploidy
1
1992
8
0.030
Why?
Prevalence
1
2014
910
0.030
Why?
Ubiquitin Thiolesterase
1
2011
9
0.030
Why?
Program Evaluation
1
2012
176
0.030
Why?
Educational Measurement
1
2012
113
0.020
Why?
Societies, Medical
1
2012
150
0.020
Why?
Genotype
1
1993
735
0.020
Why?
Austria
1
2010
3
0.020
Why?
Confidence Intervals
1
2010
141
0.020
Why?
Dermoscopy
1
2010
8
0.020
Why?
Radiotherapy
1
2010
76
0.020
Why?
Rosaniline Dyes
1
2009
19
0.020
Why?
Prospective Studies
1
2014
2046
0.020
Why?
Neoplasm, Residual
1
2009
23
0.020
Why?
Phosphoglucomutase
1
2009
5
0.020
Why?
Eyelid Diseases
1
2009
4
0.020
Why?
Intraoperative Care
1
2009
48
0.020
Why?
Sensitivity and Specificity
1
2010
533
0.020
Why?
Silver Sulfadiazine
1
2008
4
0.020
Why?
Fluocinonide
1
2008
11
0.020
Why?
Anti-Infective Agents, Local
1
2008
13
0.020
Why?
Proto-Oncogene Proteins c-kit
1
2008
24
0.020
Why?
Membrane Glycoproteins
1
2009
107
0.020
Why?
Chi-Square Distribution
1
2009
294
0.020
Why?
Azacitidine
1
2008
28
0.020
Why?
Antimetabolites, Antineoplastic
1
2008
48
0.020
Why?
Time Factors
1
2013
2014
0.020
Why?
Cohort Studies
1
2010
1701
0.020
Why?
Perineum
1
2006
14
0.020
Why?
Infant, Newborn
1
2008
605
0.020
Why?
Antineoplastic Agents
1
2010
548
0.020
Why?
Risk Factors
1
2013
3600
0.020
Why?
Mitosis
1
2005
23
0.020
Why?
Receptors, Tumor Necrosis Factor
1
2004
50
0.020
Why?
Blotting, Western
1
2005
286
0.020
Why?
Periodicals as Topic
1
2005
95
0.010
Why?
Apoptosis
1
2005
352
0.010
Why?
Leprosy
1
2002
1
0.010
Why?
Neurofibroma
1
2002
1
0.010
Why?
Antibodies, Anticardiolipin
1
2002
4
0.010
Why?
Leishmaniasis
1
2002
3
0.010
Why?
Germinal Center
1
2002
5
0.010
Why?
Clone Cells
1
2002
36
0.010
Why?
Salivary Glands, Minor
1
2002
9
0.010
Why?
Cell Line, Tumor
1
2005
692
0.010
Why?
Neoplasm Metastasis
1
2004
199
0.010
Why?
HIV-1
1
2002
45
0.010
Why?
Disease-Free Survival
1
2003
282
0.010
Why?
Breast
1
2002
53
0.010
Why?
Neurons
1
2005
395
0.010
Why?
Cholesterol
1
2002
239
0.010
Why?
Pedigree
1
1999
135
0.010
Why?
Breast Neoplasms, Male
1
1999
11
0.010
Why?
Carbon Dioxide
1
1999
36
0.010
Why?
Hysterosalpingography
1
1998
1
0.010
Why?
Laser Therapy
1
1999
52
0.010
Why?
Carcinoembryonic Antigen
1
1998
7
0.010
Why?
Forearm
1
1998
37
0.010
Why?
Cell Adhesion Molecules
1
1998
45
0.010
Why?
Depth Perception
1
1997
1
0.010
Why?
Eye Movements
1
1997
12
0.010
Why?
United States
1
2005
3693
0.010
Why?
Visual Acuity
1
1997
69
0.010
Why?
Adenocarcinoma
1
1999
302
0.010
Why?
Griseofulvin
1
1993
1
0.010
Why?
Ketoconazole
1
1993
3
0.010
Why?
Itraconazole
1
1993
6
0.010
Why?
Fluconazole
1
1993
7
0.010
Why?
Molecular Structure
1
1993
53
0.010
Why?
Sangueza's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (521)
Explore
_
Co-Authors (16)
Explore
_
Similar People (51)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_